AppLovin (APP) stock jumps 5% into next week as Wells Fargo lifts target and CPI looms
10 January 2026
2 mins read

AppLovin (APP) stock jumps 5% into next week as Wells Fargo lifts target and CPI looms

New York, Jan 10, 2026, 16:27 EST — Market closed

  • AppLovin shares climbed roughly 5% on Friday, closing near $647.72
  • Wells Fargo boosted its price target to $735 while maintaining an Overweight rating
  • Tuesday’s U.S. CPI report will serve as the next key macro checkpoint for growth stocks sensitive to rate shifts

AppLovin shares jumped roughly 5% in the last session, closing Friday around $647.72 after moving between about $612 and $650.

The rebound is significant since the stock is caught between two forces: ad demand trends and shifts in interest-rate expectations. Inflation figures due next week could shake Treasury yields, which in turn influence appetite for high-growth stocks.

For AppLovin, the immediate focus isn’t on launching new products but on whether demand stays strong in mobile and web advertising—and how that will affect guidance. Traders have been quick to sell off and just as fast to sell into any rallies.

Wells Fargo’s Alec Brondolo bumped his price target on AppLovin to $735 from $721 on Thursday, maintaining an Overweight rating that suggests the stock could outperform peers. According to a note reported by TheFly, the upgrade comes with raised Q4 revenue forecasts driven by strong mobile game data. However, the firm cautioned that “web ads trends are mixed” and flagged first-quarter consensus as “a high bar.” 1

The stock’s rise coincided with U.S. markets hitting record levels following data that revealed slower job growth in December and a drop in the unemployment rate to 4.4%, which helped maintain hopes for rate cuts. 2

AppLovin offers software and advertising solutions designed to help firms engage and monetize their audiences. The company also manages a collection of owned apps. Its lineup includes AppDiscovery, MAX, Adjust, Wurl, and Axon Ads Manager, per Reuters company data. 3

Heading into the next session, investors will watch closely for evidence that mobile advertising demand continues to grow. They’ll also want to see if the company can keep pushing beyond gaming without sacrificing pricing or returns. A shift in tone on web advertising could trigger a sharp reaction.

The next major data point on the macro front is Tuesday’s U.S. Consumer Price Index report for December, set for release at 8:30 a.m. ET. As the government’s key inflation metric, a stronger-than-expected CPI could drive yields higher and weigh on pricey tech and ad-tech stocks. 4

Technicals are clear-cut. Friday’s peak near $650 now acts as a short-term cap, with the previous session’s low around $613 serving as the first solid support.

But the setup works both ways. Wells Fargo called it a “tough setup,” and AppLovin’s upcoming guidance could weigh on the stock if the company signals caution on first-quarter demand or if ad spending slows amid changing rate forecasts.

AppLovin is set to release its fourth-quarter and full-year 2025 results on Feb. 11, right after the U.S. markets close. The company’s CEO Adam Foroughi and CFO Matthew Stumpf will then hold a webcast at 5 p.m. ET to discuss the numbers. 5

Stock Market Today

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Abbott Laboratories stock drifts into earnings after Canada widens Libre 3 Plus coverage
Previous Story

Abbott Laboratories stock drifts into earnings after Canada widens Libre 3 Plus coverage

Why Intuitive Surgical stock (ISRG) is back in focus after Bernstein lifts its target
Next Story

Why Intuitive Surgical stock (ISRG) is back in focus after Bernstein lifts its target

Go toTop